Old names:
| Owner | Filings | Transaction Date | Type of Owner |
|---|---|---|---|
| Hill Raymond H | 0001529930 | Sep-16-2011 | director, officer: Chief Executive Officer |
| SNYDERMAN RALPH | 0001178031 | May-18-2011 | director |
| BRYSON VAUGHN D | 0001189539 | May-18-2011 | director |
| INGRAM ROBERT ALEXANDER | 0001219890 | May-18-2011 | director |
| COLVIN PAUL | 0001513900 | Feb-23-2011 | officer: EVP - Clinical Development |
| Babiss Lee | 0001498376 | Oct-01-2010 | officer: Exec. VP - Global Lab Services |
| Dingivan Christine A | 0001440766 | Jul-28-2008 | officer: EVP/Chief Medical Officer |
| Wilkinson Michael O. | 0001431373 | Apr-01-2008 | officer: Executive Vice President |
| Darazsdi Daniel G | 0001412292 | Oct-01-2007 | officer: Chief Financial Officer |
| Sharbaugh William J | 0001399883 | May-31-2007 | officer: Chief Operating Officer |
| BADDOUR LINDA | 0001181151 | May-18-2007 | officer: Former Chief Financial Officer |
| Wilkinson Peter J | 0001398138 | Apr-26-2007 | officer: VP Finance/Chief Acct. Officer |
| Richardson William W | 0001343084 | Nov-01-2005 | officer: Sr. VP Global Business Dev. |
| Casieri Francis J | 0001300892 | Aug-16-2004 | officer: Sr. VP, Global Bus. Dev. |
| FOX MARYE ANNE | 0001180603 | May-19-2004 | director |
| BONDURANT STUART | 0001181152 | May-19-2004 | director |
| FRANK FRED | 0001181155 | May-19-2004 | director |
| KLEMA CATHY | 0001181157 | May-19-2004 | director |
| MAGNUSON TERRY | 0001181158 | May-19-2004 | director |
| SHANNON COLIN | 0001285101 | May-17-2004 | officer: COO--Europe |
| MARIO ERNEST | 0001180469 | Dec-31-2003 | director |
| DAVENPORT FRED B JR | 0001181154 | Dec-03-2003 | officer: President |
| HARTMAN JUDD | 0001181156 | Dec-03-2003 | officer: General Counsel |
| GRANGE DAVID L | 0001264908 | Oct-15-2003 | director |
| COVINGTON PAUL S | 0001181153 | Jun-30-2003 | officer: Executive Vice President |
| STAUB W RICHARD | 0001181162 | Jun-30-2003 | officer: Sr. Vice President |
| MCNEILL JOHN A JR | 0001033408 | Jun-19-2003 | director |
| ESHELMAN FREDRIC N | 0001033409 | Jun-17-2003 | director, 10 percent owner, officer: Chief Executive Officer |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
| Filings | Format | Description | Filed/Effective | File/Film Number |
|---|---|---|---|---|
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950157-24-000416 (34 Act) Size: 0 KB |
Mar-14-2024 | 24750563 |
| 3/A | Document | Amendment to Initial statement of beneficial ownership of securities Acc-no: 0001628280-21-022213 (34 Act) Size: KB |
Nov-08-2021 | 211387992 |
| 3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001628280-21-020187 (34 Act) Size: 0 KB |
Oct-18-2021 | 211328706 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001104659-18-048806 (34 Act) Size: 0 KB |
Aug-01-2018 | 18985713 |
| 3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001104659-18-047104 (34 Act) Size: 0 KB |
Jul-25-2018 | 18969883 |
| CT ORDER | Document | Acc-no: 9999999997-14-001000 (34 Act) Size: KB | Feb-18-2014 | 14620552 |
| CT ORDER | Document | Acc-no: 9999999997-13-017300 (34 Act) Size: KB | Dec-16-2013 | 131278123 |
| 15-12G | Document | Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001193125-11-341802 (34 Act) Size: KB |
Dec-15-2011 | 111262589 |
| S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-11-331954 (33 Act) Size: KB |
Dec-06-2011 | 111245684 |
| S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-11-331941 (33 Act) Size: KB |
Dec-06-2011 | 111245658 |
| S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-11-331940 (33 Act) Size: KB |
Dec-06-2011 | 111245657 |
| S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-11-331939 (33 Act) Size: KB |
Dec-06-2011 | 111245656 |
| S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-11-331937 (33 Act) Size: KB |
Dec-06-2011 | 111245649 |
| S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-11-331936 (33 Act) Size: KB |
Dec-06-2011 | 111245646 |
| S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-11-331932 (33 Act) Size: KB |
Dec-06-2011 | 111245643 |
| S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-11-331929 (33 Act) Size: KB |
Dec-06-2011 | 111245642 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001529930-11-000003 ( Act) Size: 0 KB |
Dec-06-2011 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001178031-11-000006 ( Act) Size: 0 KB |
Dec-06-2011 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001399883-11-000004 ( Act) Size: 0 KB |
Dec-06-2011 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001343084-11-000004 ( Act) Size: 0 KB |
Dec-06-2011 |
Recent 20 filings. View all PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC filings
Thanks I look forward to using the product to improve my skin tone
Very good communication and delivery made within the timeframe I was advised of
young lad who new his job ansered questions and new what was best for me.
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by